{"id": "1337071454899331073", "creation": 1607617651.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Moderna Announces First Participants Dosed in Phase 2/3 Study of #COVID19 #Vaccine Candidate in Adolescents\n\nThe first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18.\nhttps://t.co/WuC39RYVtS", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}